Experimental Hematology

Journal for Hematology, Stem Cell Biology and Transplantation Official Publication of the ISEH - International Society for Hematology

Experimental Hematology - ISSN 0301-472X
Source Normalized Impact per Paper (SNIP): 0.5 Source Normalized Impact per Paper (SNIP):
SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SCImago Journal Rank (SJR): 1.341 SCImago Journal Rank (SJR):
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Impact Factor: 2.303 (2015) Impact Factor:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Thomson Reuters Journal Citation Reports 2015
5 Year Impact Factor: 2.356 (2015) Five-Year Impact Factor:
To calculate the five year Impact Factor, citations are counted in 2014 to the previous five years and divided by the source items published in the previous five years.
© Journal Citation Reports 2015, Published by Thomson Reuters
Volumes: Volumes 45-56
Issues: 12 issues
ISSN: 0301472X

Personal Subscription

Tax/VAT will be calculated at check-out

Shop With Confidence

  • Free Shipping around the world
  • Broad range of products


Experimental Hematology is the official Journal of the International Society for Experimental Hematology.

Experimental Hematology brings you original research articles and current, authoritative reviews on all aspects of hematology, with emphasis on the biology of normal and malignant hematopoiesis, as well as non-malignant hematologic disorders. Additionally, the journal covers submissions with clear relevance to hematology in the following topic areas: non-hematopoietic stem cells (e.g. mesenchymal stem cells, embryonic stem cells and induced pluripotent stems); translational or early phase clinical studies, disease pathogenesis or therapy; and novel techniques or animal models, genomics and systems biology analyses of hematological networks.

Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center